Finorion Pharma India Private Limited - Company Profile

It is a pharma private limited company based in Mumbai, Maharashtra, India, established in 2011.

2011 Mumbai, Maharashtra, India Active

Last Updated: January 09, 2026

About Finorion Pharma India Private Limited

Finorion Pharma India Private Limited, a active private limited company, was established on 23 December 2011 in Mumbai, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the support service to organizations sector, it holds CIN: U74120MH2011PTC225361. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.50 M.

It upholds a compliant status. Employing 149 professional, Its leadership includes Olli Heikki Huotari (Director), Samrudhi Mangesh Utturkar (Director), Rene Kristian Lindell (Director). Past directors included Olli Heikki Huotari, Kalyani Avinash Hendre, Jari Ilmari Karlson. Its latest AGM occurred on 22 September 2025, with the balance sheet filed on 31 March 2025. It is based at Smartworks Coworking Location, Times Square Building, 9Th Floor, C Wing, Andheri Marol, Andheri East, Mumbai, Mumbai, Maharashtra, 400059.

Company Details

CIN/LLPIN
U74120MH2011PTC225361
Registration Number
225361
Incorporation Date
23 December 2011
Authorized Capital
₹0.50 M
Paid-Up Capital
₹0.50 M
ROC Code
Roc Mumbai
Listing Status
Unlisted
Company Status
Active

Key Metrics

Authorised Capital ₹ 0.50 M as on 09-01-2026
Paid Up Capital ₹ 0.50 M as on 09-01-2026
Company Age 14 Year, 1 Month
Last Filing with ROC 31 Mar 2025
Revenue Growth **** 6.58% (FY 2023)
Profit Growth **** 17.34% (FY 2023)
Ebitda **** 2.17% (FY 2023)
Net Worth 16.08% (FY 2023)
Total Assets **** 12.50% (FY 2023)

Comprehensive Company Insights

Explore comprehensive insights into Finorion Pharma India Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Finorion Pharma India Private Limited?

Current Directors

Name	Designation	Appointment Date	Status
Olli Heikki Huotari	Director	23 Dec 2011	Current
Samrudhi Mangesh Utturkar	Director	29 May 2018	Current
Rene Kristian Lindell	Director	05 Aug 2024	Current
Johanna Linnea Pakkanen	Director	24 Nov 2015	Current
Mikko Tapani Kemppainen	Director	24 Apr 2025	Current
Pekka Juhani Kankaanpaa	Director	24 Apr 2025	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Director	31 Mar 2025	Past
Pramod Abcsdd	Director	29 May 2018	Past
Pramod Abcsdd	Director	05 Mar 2024	Past
Pramod Abcsdd	Additional Director	25 Sep 2018	Past
Pramod Abcsdd	Additional Director	19 Sep 2024	Past
Pramod Abcsdd	Additional Director	21 Sep 2016	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Finorion Pharma India.

Finorion Pharma India Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 6.58% increase. The company also saw a substantial improvement in profitability, with a 17.34% increase in profit. The company's net worth Soared by an impressive increase of 16.08%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

6.58%

*******

Revenue from Operations

*******

5.26%

*******

Total Assets

*******

12.50%

*******

Profit or Loss

*******

17.34%

*******

Net Worth

*******

16.08%

*******

EBITDA

*******

2.17%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Finorion Pharma India?

In 2023, Finorion Pharma India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Finorion Pharma India?

Finorion Pharma India has a workforce of 149 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Finorion Pharma India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Finorion Pharma India's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Finorion Pharma India

Recent Activity within the Organization

Annual General Meeting

Progress on Finorion Pharma India Private Limited last Annual general meeting of members was held on 22 Sep 2025 as per latest MCA records. was documented.
22 Sep 2025
Director Appointment

Progress on Mikko Tapani Kemppainen was appointed as a Director was appointed as a Director on 24 Apr 2025 & has been associated with this company since 9 months 26 days . was documented.
24 Apr 2025
Director Appointment

Progress on Pekka Juhani Kankaanpaa was appointed as a Director was appointed as a Director on 24 Apr 2025 & has been associated with this company since 9 months 26 days . was documented.
24 Apr 2025
Balance Sheet

The activity Finorion Pharma India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was completed.
31 Mar 2025
Director Appointment

Progress on Rene Kristian Lindell was appointed as a Director was appointed as a Director on 05 Aug 2024 & has been associated with this company since 1 year 6 months . was documented.
05 Aug 2024
Director Appointment

Progress on Samrudhi Mangesh Utturkar was appointed as a Director was appointed as a Director on 29 May 2018 & has been associated with this company since 7 years 8 months . was documented.
29 May 2018

Explore recent activity and updates - View Recent Activity